Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Plos One
|
January 7, 2014
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug
Cecilia Garofalo, Mariantonietta Capristo, Maria Cristina Manara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2009
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells
Laura Menotti, Giordano Nicoletti, Valentina Gatta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2002
HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells
Cinzia Ricci, Letizia Polito, Patrizia Nanni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2006
Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role
Arianna Palladini, Annalisa Astolfi, Stefania Croci, et al.
Cancers
|
April 14, 2019
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.
Cell Communication and Signaling : CCS
|
October 11, 2024
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, et al.
Cancer Research
|
June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice
Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Oncoimmunology
|
September 18, 2018
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
Patrizia Nanni, Carla De Giovanni, Alessia Burocchi, et al.
Journal of Cell Communication and Signaling
|
November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
Michela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.
Cancer Research
|
November 19, 2004
Immunological prevention of a multigene cancer syndrome
Stefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Plos One
|
January 7, 2014
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug
Cecilia Garofalo, Mariantonietta Capristo, Maria Cristina Manara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2009
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells
Laura Menotti, Giordano Nicoletti, Valentina Gatta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2002
HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells
Cinzia Ricci, Letizia Polito, Patrizia Nanni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2006
Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role
Arianna Palladini, Annalisa Astolfi, Stefania Croci, et al.
Cancers
|
April 14, 2019
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.
Cell Communication and Signaling : CCS
|
October 11, 2024
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, et al.
Cancer Research
|
June 5, 2003
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice
Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Oncoimmunology
|
September 18, 2018
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
Patrizia Nanni, Carla De Giovanni, Alessia Burocchi, et al.
Journal of Cell Communication and Signaling
|
November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
Michela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.
Cancer Research
|
November 19, 2004
Immunological prevention of a multigene cancer syndrome
Stefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
Page
of 9